Sectoral Report: Pharmaceuticals (April 2022)
Greek pharma industry: In position to capitalize on EU shift towards more self-reliance
- Who we are
- Investor relations
- Financial data and results
- Financial Calendar
- Results' press releases
- Presentations
- Audio - visual files
- Financial Tables
- Annual and interim financial statements
- Public Offering of shares in the National Bank of Greece by the Hellenic Financial Stability Fund -2023
- Public Offering of shares in the National Bank of Greece by the Hellenic Financial Stability Fund -2024
- Annual reports and offering circulars
- General meetings
- NBG share
- Notification of transactions
- Contact information
- Debt investors
- Credit ratings
- Outstanding debt issuances
- Fixed income presentations
- Sustainability and green bond frameworks
- Covered bonds
- Medium term notes
- Additional Tier 1 (AT1)
- Cash flow statements
- Economic Analysis & Research
- Greek economy
- Macro Flash
- Macro Outlook
- Special Focus Reports
- Greek Entrepreneurship
- Entrepreneurship reports
- Surveys on SMEs
- Sectoral reports
- Business trends
- Southeastern Europe & Mediterranean Emerging Market Economies
- Bi-Weekly report
- Quarterly Chartbook
- Banking Sector Overview
- Special Issues
- Global Economy & Financial Markets
- Weekly Global Markets Roundup
- Global and Regional Economic Factbooks
- Global Markets Strategy & Outlook
- ESG - Environment Society & Governance
- Our vision and strategy
- Reports & Data ESG
- Participation in organizations - Benchmarks
- Our environment
- Sustainable development
- Our environmental footprint
- Initiatives and actions for tomorrow
- The benefit of ESG for enterprises and the Greek economy
- Our society
- Our actions for society
- Health and education for all
- NBG Cultural Foundation
- Historical Archive
- NBG Library
- Our customers
- Program Responsibility
- Sponsorships
- Our Corporate Governance
- Board of Directors
- BoD Committees
- Management and organizational structure
- Corporate Governance Framework
- Shareholder structure
- Whistleblowing report submission
- Human Resources
- Press Office
Sectoral Report: Pharmaceuticals (April 2022)
- NBG Group
- Economic Analysis and Research
- Sectoral Report: Pharmaceuticals (April 2022)
Close
Close